Over the counter consumer health business have been a key focus area for pharma firms in the recent past. In fact, last year saw quite a few prescription (Rx) products switch over to OTC portfolio of leading pharmaceutical firms like Lupin and Cipla.
Consumer health products do not require prescription from doctors and can be purchased over the counter (OTC). With the Covid-19 pandemic raging, analysts expect the focus on OTC brands to continue as doctor connect is limited. In its FY20 annual report, Sun Pharmaceutical Industries, one of the top ten consumer health companies in ...
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs
Key stories on business-standard.com are available to premium subscribers only.
Already a premium subscriber? LOGIN NOW
Copyrights © 2020 Business Standard Private Ltd. All rights reserved.
